Clinical Trial Update: 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating 68Ga-NODAGA-exendin-4 PET/CT for diagnostic imaging in insulinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulinoma

Drugs mentioned

• 68Ga-NODAGA-exendin-4 (exendin-4)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Insulinoma | Phase 1, Phase 2 | Status: COMPLETED